Skip to content
NovaVoice

Giving Stem Cells During Pregnancy to Infants with Neural Tube Defect Improves Quality of Life, Trial Finds

A pioneering research effort has found that delivering regenerative cells to fetuses suffering from spina bifida as part of a surgical repair may represent a "major milestone" in addressing congenital conditions.

Trial Details and Safety

The US-based trial examined six unborn babies with myelomeningocele. Surgeons applied placenta-derived mesenchymal stem cells to the surface of the developing neural column while the defect was being closed.

Importantly, the cell therapy was found to be safe. Doctors verified that the therapy did not induce neoplasms, disrupt the healing process, or prevent the reversal of related neurological issues.

Promising Outcomes

Magnetic resonance imaging performed on the newborns showed a full resolution of hindbrain herniation in each of the babies. This brain structure normalization is strongly associated with enhanced physical outcomes.

"Should it enable more children able to walk who wouldn't have, it could establish itself as their standard of care," noted the study director. "The results are super exciting and open the door to lots of potential innovative interventions."

Broader Impact and Encouragement

Commentators reviewing the findings proposed that subsequent studies of these noted improvements could signal a "different age" in prenatal intervention. The possibility of ameliorating neurological damage present before birth is viewed as a paradigm-shifting aim.

Notably important would be improvements in continence and digestive health, which are frequent complications for individuals living with this condition.

The Path Forward

Despite this being a first-in-human effort was small in scale, its safety demonstration and positive signals offer a robust platform for larger, more comprehensive studies. The integration of stem cell therapy with current in-utero repair procedures presents significant potential for improving the prognosis for infants diagnosed prenatally with myelomeningocele.

Written by

Aaron Dickson

A tech strategist with over a decade of experience in digital transformation and AI integration, passionate about empowering businesses through innovation.

NovaVoice

Type to search articles.